Xingrong Liu
Gilead Sciences (United Kingdom)(GB)Gilead Sciences (United States)(US)Lanzhou University(CN)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Parkinson's Disease Mechanisms and Treatments, Alzheimer's disease research and treatments, Pharmacological Effects and Toxicity Studies, Computational Drug Discovery Methods
Most-Cited Works
- → Ser 1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations(2012)373 cited
- → Effect of selective LRRK2 kinase inhibition on nonhuman primate lung(2015)364 cited
- → Use of a Physiologically Based Pharmacokinetic Model to Study the Time to Reach Brain Equilibrium: An Experimental Analysis of the Role of Blood-Brain Barrier Permeability, Plasma Protein Binding, and Brain Tissue Binding(2005)182 cited
- → Progress in Brain Penetration Evaluation in Drug Discovery and Development(2008)176 cited
- → Rational Use of Plasma Protein and Tissue Binding Data in Drug Design(2014)173 cited
- → Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors(2012)161 cited